Anti-CXCL1/GRO alpha + CXCL2 + GRO gamma 抗体
Anti-CXCL1/GRO alpha + CXCL2 + GRO gamma antibody [EPR4903]
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal CXCL1/GRO alpha antibody. Suitable for WB and reacts with Recombinant fragment - Human samples. Cited in 2 publications.
別名を表示する
GRO, GRO1, GROA, MGSA, SCYB1, CXCL1, Growth-regulated alpha protein, C-X-C motif chemokine 1, GRO-alpha(1-73), Melanoma growth stimulatory activity, Neutrophil-activating protein 3, NAP-3
- WB
Unknown
Western blot - Anti-CXCL1/GRO alpha + CXCL2 + GRO gamma antibody [EPR4903] (AB124731)
All lanes:
Western blot - Anti-CXCL1/GRO alpha + CXCL2 + GRO gamma antibody [EPR4903] (ab124731) at 1/10000 dilution
All lanes:
CXCL1/GRO alpha recombinant protein at 0.005 µg
false
- WB
Supplier Data
Western blot - Anti-CXCL1/GRO alpha + CXCL2 + GRO gamma antibody [EPR4903] (AB124731)
Blocking and diluting buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-CXCL1/GRO alpha + CXCL2 + GRO gamma antibody [EPR4903] (ab124731) at 1/1000 dilution
Lane 1:
His-tagged Human CXCL1(GRO alpha) recombinant protein (aa35-107) at 10 ng
Lane 2:
His-tagged Human CXCL2(GRO beta) recombinant protein (aa35-107) at 10 ng
Lane 3:
His-tagged Human CXCL3(GRO gamma) recombinant protein (aa35-107) at 50 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
Exposure time: 7s
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-CXCL1/GRO alpha + CXCL2 + GRO gamma antibody [EPR4903] (AB124731)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-CXCL1/GRO alpha + CXCL2 + GRO gamma antibody [EPR4903] - BSA and Azide free
Reactivity data
製品の詳細
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CXCL1/GRO alpha CXCL2 and GRO gamma are involved in the recruitment and activation of neutrophils. Neutrophils are the first responders in the immune response. These chemokines play a role in angiogenesis and wound healing by stimulating the migration and proliferation of endothelial cells. They do not function as part of a larger protein complex but operate independently in signaling pathways. Their chemotactic activities are essential for proper immune surveillance and response to infections.
Pathways
These chemokines are integral to the NF-kB signaling pathway and MAPK pathway. Through these pathways they mediate inflammatory responses and cellular proliferation. CXCL1/GRO alpha and its family members interact with proteins such as CXCR2 and MAPK which help relay signals for gene expression related to inflammation and cell survival. Their interaction with these pathways highlights their role in initiating and modulating inflammatory processes.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
追加のターゲット
文献 (2)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 25: PubMed39408697
2024
Applications
Unspecified application
Species
Unspecified reactive species
Inflammopharmacology 30:2345-2357 PubMed36131109
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com